![Nicholas Plummer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicholas Plummer
General Counsel at
VOLITIONRX LIMITED
Net worth: 14 621 $ as of 2026-07-30
Profile
Nicholas Plummer is currently Group General Counsel at VolitionRX Ltd. since 2021.
Former positions include Secretary & General Counsel at Ark Therapeutics Group Plc from 2004 to 2008, Secretary & General Counsel at Novacyt SA, Managing Counsel-Europe at Patheon France SAS from 2013 to 2021, and a role at Ashurst Morris Crisp from 2004 to 2007.
Education includes a graduate degree from The University of Reading.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VOLITIONRX LTD 0.17% | 2026-03-16 | 20,363 ( 0.17% ) | 14 621 $ | 2026-07-30 |
Nicholas Plummer active positions
| Companies | Position | Start |
|---|---|---|
| VOLITIONRX LIMITED | General Counsel | 2021-10-31 |
Former positions of Nicholas Plummer
| Companies | Position | End |
|---|---|---|
Patheon France SAS
 Patheon France SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 2020-12-31 |
Ark Therapeutics Group Plc
 Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Discovers and develops medicinal gene-based and biological therapies and diagnostic products | General Counsel | 2007-12-31 |
| NOVACYT | General Counsel | - |
Training of Nicholas Plummer
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
28
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Discovers and develops medicinal gene-based and biological therapies and diagnostic products | Commercial Services |
The University of Reading
 The University of Reading Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novacyt SAS
 Novacyt SAS Medical SpecialtiesHealth Technology Designs, develops and markets molecular real-time PCR testing devices and reagents in the areas of infectious diseases | Health Technology |
Patheon France SAS
Patheon France SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
VolitionRX Ltd.
 VolitionRX Ltd. Medical SpecialtiesHealth Technology Develops blood tests to help diagnose a range of cancers and other diseases | Health Technology |
- Stock Market
- Insiders
- Nicholas Plummer
